Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading Update

19 Sep 2018 07:00

RNS Number : 1814B
Babcock International Group PLC
19 September 2018
 

19 September 2018

Babcock International Group PLC (Babcock or the Group)

Trading update

 

Babcock, the engineering services company, is issuing the following trading update for the period from 1 April 2018. This follows a trading update issued on 19 July 2018.

 

Trading in line, outlook unchanged

The Group is trading in line with our expectations and our order book and pipeline remain strong with a combined value unchanged at around £32 billion (c.£18 billion order book and c.£14 billion pipeline). Around 87% of revenue is now in place for 2018/19 and around 57% for 2019/20.

 

Strategic progress

During 2017 we successfully completed the realignment of the Group management and operating structure into four sectors: Marine, Land, Aviation and Cavendish Nuclear. This realignment has intensified our concentration on core higher-margin strategic businesses and is increasing our focus on three core markets: defence, emergency services and nuclear. These markets already account for around three quarters of our revenue and offer sustainable growth opportunities, particularly internationally.

 

In July we advised that we intended to exit a number of non-strategic, small, low-margin businesses in our Land sector. We have now exited our North American mining and construction support business and have agreed the sale of our Media Services business for around £30 million, with the sale expected to complete in the coming months. This follows the exit from our renewables and civil infrastructure businesses in the UK last year.

 

This process will continue in the second half of this year, where we expect to exit our powerlines business in South Africa. We will also reshape our oil and gas crew change business to improve performance while ensuring we meet customer needs. We will provide an update on these activities with the announcement of our half year results in November.

 

Operational progress

Our strategy is delivered across our four sectors. Progress in the period included:

· Marine secured a five year Ship Naval Design Partnering (NDP) contract with the Ministry of Defence (MOD) with options for extension. This important long term contract provides leadership for the industry development of new naval platforms and mission systems on behalf of the MOD. In our Energy business, we reinforced the introduction of our ecoSMRT technology by securing a further seven liquid gas equipment systems contracts from international customers

· Land has been awarded additional contracts worth around £120 million with the Ministry of Defence to maintain equipment as part of our DSG contract and we have been named the preferred bidder for a rail services contract in Northern Ireland worth over £100 million

· Aviation's new HADES contract to provide technical support at RAF bases is now fully operational. Our French FOMEDEC flight training contract is moving into the pre-operational phase, with the manufacture of all 17 PC21 aircraft completed and simulators being commissioned in the new centre in Cognac

· Nuclear has been selected as preferred bidder for the Dounreay Materials Test Reactor decommissioning contract and we have begun work on the scheduled outage at EDF's Dungeness station. Activity on new build continues to increase as design programmes accelerate in preparation for construction at Hinkley Point C

 

We continue to make significant progress in expanding our international businesses, including the progress on FOMEDEC. We have won contracts for fire services in Australia and aerial emergency services in Finland and we are opening offices in South Korea and Japan to support ongoing contracts and to develop new business opportunities.

 

Outlook for the Group

The outlook for the year is unchanged:

· We expect low single digit underlying organic revenue growth at constant currency for the full year with stable margins

· Underlying earnings guidance remains unchanged and as previously indicated, revenue and cash flow performance will be second half weighted as has been the case for a number of years

· We expect to continue to reduce our debt during the year and expect our net debt to EBITDA ratio to be around 1.4 times by the end of the year

 

Ends

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)20 3 235 5592 Tel: +44 (0)20 7355 5312

 

FTI Consulting

Andrew Lorenz

Nick Hasell

Tel: +44 (0)20 3737 1340

 

 

Conference call

 

A conference call for analysts and investors will be held at 08:00 (UK time) this morning, hosted by Archie Bethel (Chief Executive) and Franco Martinelli (Group Finance Director).

 

The dial in number is +44 20 3059 5868. Please state you wish to join the Babcock trading update when prompted.

 

A replay of this call and transcript will be made available at www.babcockinternational.com/investors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFSFAAFASEEU
Date   Source Headline
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:36 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:02 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20255:00 pmRNSNotice of AGM
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20256:27 pmRNSLaunch of Share Buyback Programme
7th Jul 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jul 20253:57 pmRNSDirector/PDMR Shareholding
1st Jul 20255:41 pmRNSFinal Results
25th Jun 20257:00 amRNSPreliminary results for the year ended 31.03.2025
17th Jun 20253:30 pmRNSHolding(s) in Company
10th Jun 20251:11 pmRNSHolding(s) in Company
9th Jun 20254:23 pmRNSDirector Announcement
5th Jun 20259:00 amRNSDirectorate Change
20th May 202512:48 pmRNSBabcock host Cavendish Nuclear teach-in event
23rd Apr 20257:00 amRNSFY25 Post-close Trading Update
26th Mar 20257:30 amRNSBabcock awarded five-year British Army contract
19th Mar 20256:00 pmRNSHargreaves Lansdown
7th Feb 20253:16 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSQ3 trading update and upgrade of FY25 expectations
30th Jan 20254:05 pmRNSHolding(s) in Company
21st Jan 20253:55 pmRNSDirector/PDMR Shareholding
27th Nov 202411:37 amRNSDirector/PDMR Shareholding
18th Nov 20243:06 pmRNSDirector/PDMR Shareholding
18th Nov 20242:34 pmRNSChange of Record Date for Interim Dividend
14th Nov 20244:33 pmRNSDirector/PDMR Shareholding
14th Nov 202411:50 amRNSDirector announcement
13th Nov 20247:00 amRNSResults for the six months ended 30 September 2024
4th Oct 20242:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20244:13 pmRNSDirector/PDMR Shareholding
1st Oct 20243:04 pmRNSHolding(s) in Company
30th Sep 20243:41 pmRNSDirector/PDMR Shareholding
26th Sep 20242:49 pmRNSDirector/PDMR Shareholding
19th Sep 20243:35 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM trading update
6th Sep 202411:48 amRNSDirector/PDMR Shareholding
29th Aug 20244:33 pmRNSDirector/PDMR Shareholding - Replacement
29th Aug 20241:26 pmRNSDirector/PDMR Shareholding
15th Aug 20241:01 pmRNSNotice of AGM
7th Aug 20249:44 amRNSDirector/PDMR Shareholding
6th Aug 202411:28 amRNSDirector/PDMR Shareholding
5th Aug 20244:26 pmRNSDirector/PDMR Shareholding
2nd Aug 202412:02 pmRNSDirector/PDMR Shareholding
1st Aug 20243:48 pmRNSDirector/PDMR Shareholding
30th Jul 20249:53 amRNSAnnual Financial Report
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.